Les médicaments marqués en jaune ont la description texte.
- ABRILADA /solution/: adalimumab (40)
- ABRILADA /solution/: adalimumab (40)
- ABRILADA /solution/: adalimumab (20)
- AMGEVITA /solution/: adalimumab (50)
- AMGEVITA /solution/: adalimumab (50)
- AMGEVITA /solution/: adalimumab (50)
- AVSOLA /poudre pour solution/: infliximab (100)
- BRENZYS /solution/: etanercept (50)
- BRENZYS /solution/: etanercept (50)
- CIMZIA /solution/: certolizumab pegol (200)
- CIMZIA /solution/: certolizumab pegol (200)
- ENBREL /solution/: etanercept (50)
- ERELZI /solution/: etanercept (50)
- ERELZI /solution/: etanercept (25)
- ERELZI /solution/: etanercept (50)
- HADLIMA /solution/: adalimumab (40)
- HADLIMA /solution/: adalimumab (40)
- HADLIMA PUSHTOUCH /solution/: adalimumab (40)
- HADLIMA PUSHTOUCH /solution/: adalimumab (40)
- HULIO /solution/: adalimumab (40)
- HULIO /solution/: adalimumab (20)
- HULIO /solution/: adalimumab (40)
- HUMIRA /solution/: adalimumab (40)
- HUMIRA /solution/: adalimumab (20)
- HYRIMOZ /solution/: adalimumab (20)
- HYRIMOZ /solution/: adalimumab (40)
- HYRIMOZ /solution/: adalimumab (40)
- IDACIO /solution/: adalimumab (40)
- IDACIO /solution/: adalimumab (40)
- INFLECTRA /poudre pour solution/: infliximab (100)
- REMICADE /poudre pour solution/: infliximab (100)
- REMSIMA SC /solution, trousse/: infliximab (120)
- RENFLEXIS /poudre pour solution/: infliximab (100)
- SIMLANDI /solution/: adalimumab (40)
- SIMLANDI /solution/: adalimumab (40)
- SIMLANDI /solution/: adalimumab (80)
- SIMPONI /solution/: golimumab (100)
- SIMPONI /solution/: golimumab (100)
- SIMPONI /solution/: golimumab (50)
- SIMPONI /solution/: golimumab (50)
- SIMPONI I.V. /solution/: golimumab (50)
- YUFLYMA /solution/: adalimumab (80)
- YUFLYMA /solution/: adalimumab (80)
- YUFLYMA /solution/: adalimumab (40)
- YUFLYMA /solution/: adalimumab (40)
45 médicaments correspondent à la recherche.